Pure Global AI
NCT05972694Not yet recruiting

Effect of Grapes in Inflammatory Bowel Disease

The Effect of Grapes in Inflammatory Bowel Disease
Case Western Reserve UniversityClinicalTrials.govdietary supplement
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Freeze dried grape powder
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Case Western Reserve University
Timeline & enrollment
Phase
N/A
Start date
Apr 02, 2024
End date
Oct 02, 2025
Enrollment
20 participants
Primary outcome

fecal microbiota composition

Summary

The overall objective of this pilot intervention study is to determine the impact of grape
 powder (46g/day freeze dried whole grape powder provided by the California Table Grape
 Commission) on the gut microbiotacomposition in adult patients with the IBD subtype Crohn's
 disease (CD).

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05972694
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05972694 through Pure Global AI's free database. This phase not specified trial is sponsored by Case Western Reserve University and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.